Michael J. Morrison

A quantitative analysis of kinase inhibitor selectivity

Mazen W. Karaman, Sanna Herrgård, Daniel K. Treiber et al. · Nature Biotechnology · 2008 · 2.4K citations

Drug Target, Signal Transduction, Medicine +6

Evolution of a Highly Selective and Potent 2-(Pyridin-2-yl)-1,3,5-triazine Tie-2 Kinase Inhibitor

Brian L. Hodous, Stephanie Geuns-Meyer, Paul E. Hughes et al. · Journal of Medicinal Chemistry · 2007 · 91 citations · Full text

Molecular Biology, Pharmacotherapy, Chemical Biology +21

Engineered High-Affinity Affibody Molecules Targeting Platelet-Derived Growth Factor Receptor β In Vivo

Malin Lindborg, Eliane Cortez, Ingmarie Höidén‐Guthenberg et al. · Journal of Molecular Biology · 2011 · 85 citations

Drug Targeting, Blood Platelet, High-affinity Affibody Molecules +4

Biochemical Characterization of the O-Linked Glycosylation Pathway in <i>Neisseria gonorrhoeae</i> Responsible for Biosynthesis of Protein Glycans Containing <i>N</i>,<i>N</i>′-Diacetylbacillosamine

Meredith D. Hartley, Michael J. Morrison, Finn Erik et al. · Biochemistry · 2011 · 81 citations

Bioorganic Chemistry, Glycobiology, Pgl Enzymes +19

Novel 2,3-Dihydro-1,4-Benzoxazines as Potent and Orally Bioavailable Inhibitors of Tumor-Driven Angiogenesis

Daniel S. La, Julie Belzile, James Bready et al. · Journal of Medicinal Chemistry · 2008 · 73 citations · Full text

Pharmacotherapy, Pharmaceutical Chemistry, Novel 2,3-Dihydro-1,4-benzoxazines +20